Animal Carcinogenicity Studies: 1. Poor Human Predictivity
暂无分享,去创建一个
[1] L. Gold,et al. Supplement to the Carcinogenic Potency Database (CPDB): results of animal bioassays published in the general literature in 1993 to 1994 and by the National Toxicology Program in 1995 to 1996. , 1999, Environmental health perspectives.
[2] Iarc Monograhs,et al. 3. Studies of Cancer in Experimental Animals , 2008 .
[3] L. Gold,et al. Supplement to the Carcinogenic Potency Database (CPDB): results of animal bioassays published in the general literature through 1997 and by the National Toxicology Program in 1997-1998. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[4] S. Epstein. The politics of cancer revisited , 1998 .
[5] C. Coggins. National Toxicology Program '"Report on Carcinogens (Ninth Edition)": Environmental Tobacco Smoke , 1998 .
[6] Will all chemicals be carcinogenic to rodents when adequately evaluated? , 1993, Mutagenesis.
[7] B. Ames,et al. What do animal cancer tests tell us about human cancer risk?: Overview of analyses of the carcinogenic potency database. , 1998, Drug metabolism reviews.
[8] P. Sandercock,et al. Where is the evidence that animal research benefits humans? , 2004, BMJ : British Medical Journal.
[9] Epstein,et al. The politics of cancer , 2000, JAMA.
[10] J Ashby,et al. Alternatives to the 2-species bioassay for the identification of potential human carcinogens , 1996, Human & experimental toxicology.
[11] V. Beral,et al. IARC MONOGRAPHS PROGRAMME ON THE EVALUATION OF CARelNOGENIC RISKS TO HUMANS' , 2008 .
[12] F. M. Johnson. Response to Tennant et al.: Attempts to replace the NTP rodent bioassay with transgenic alternatives are unlikely to succeed , 2001 .
[13] Shelly Puleo. US Environmental Protection Agency , 1982 .
[14] W. Viscusi,et al. Synthetic risks, risk potency, and carcinogen regulation. , 1998, Journal of policy analysis and management : [the journal of the Association for Public Policy Analysis and Management].
[15] A. Monro,et al. Evaluation of the Carcinogenic Potential of Pharmaceuticals , 1998, Drug safety.
[16] M. Pike,et al. The TD50: a proposed general convention for the numerical description of the carcinogenic potency of chemicals in chronic-exposure animal experiments. , 1984, Environmental health perspectives.
[17] S. Fukushima,et al. Effects of butylated hydroxyanisole, butylated hydroxytoluene, and NaCl on gastric carcinogenesis initiated with N-methyl-N'-nitro-N-nitrosoguanidine in F344 rats. , 1984, Journal of the National Cancer Institute.
[18] Lester B Lave,et al. Implications of the lack of accuracy of the lifetime rodent bioassay for predicting human carcinogenicity. , 2003, Regulatory toxicology and pharmacology : RTP.
[19] F. K. Ennever,et al. The predictivity of animal bioassays and short-term genotoxicity tests for carcinogenicity and non-carcinogenicity to humans. , 1987, Mutagenesis.
[20] J. Huff,et al. The carcinogenesis bioassay in perspective: application in identifying human cancer hazards. , 1995, Environmental health perspectives.
[21] Thomas H. Parker,et al. What is π , 1991 .
[22] J. Huff,et al. Long‐Term Chemical Carcinogenesis Bioassays Predict Human Cancer Hazards: Issues, Controversies, and Uncertainties , 1999, Annals of the New York Academy of Sciences.
[23] D. Rall. LABORATORY ANIMAL TESTS AND HUMAN CANCER* , 2000, Drug metabolism reviews.
[24] G. Swaen,et al. The predictive value of animal data in human cancer risk assessment. , 1997, Regulatory toxicology and pharmacology : RTP.
[25] A. Aitio,et al. Human Carcinogens So Far Identified , 1989, Japanese journal of cancer research : Gann.
[26] M. Plummer,et al. International agency for research on cancer. , 2020, Archives of pathology.
[27] A. Agresti,et al. Approximate is Better than “Exact” for Interval Estimation of Binomial Proportions , 1998 .
[28] M. Stephens,et al. Unrelieved pain and distress in animals: an analysis of USDA data on experimental procedures. , 1998, Journal of applied animal welfare science : JAAWS.
[29] U. Epa. Guidelines for carcinogen risk assessment , 1986 .
[30] J. Kaldor,et al. Response of experimental animals to human carcinogens: an analysis based upon the IARC Monographs programme. , 1986, Carcinogenesis.
[31] L. Bernstein,et al. Interspecies extrapolation in carcinogenesis: prediction between rats and mice. , 1989, Environmental health perspectives.
[32] A. Monro. Are lifespan rodent carcinogenicity studies defensible for pharmaceutical agents? , 1996, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.
[33] J K Haseman,et al. USING THE NTP DATABASE TO ASSESS THE VALUE OF RODENT CARCINOGENICITY STUDIES FOR DETERMINING HUMAN CANCER RISK , 2000, Drug metabolism reviews.